人体干细胞衍生β细胞表达优化的CD155减少细胞毒性免疫细胞功能,适用于1型糖尿病
Matthew E Brown1,2, Jessie M Barra1,3, Marcus R Pina1,2
1Diabetes Institute, University of Florida, Gainesville, FL, USA.
bioRxiv : the preprint server for biology
|August 20, 2025
概括
具有高亲和度CD155的工程干细胞衍生β细胞 (sBC) 减少免疫攻击,为1型糖尿病 (T1D) 提供了有前途的新疗法. 这种方法增强了免疫逃避,改善了潜在的恢复性治疗的sBC生存率.
科学领域:
- 免疫学 免疫学 免疫学
- 干细胞生物学 干细胞生物学
- 内分泌学 在内分泌学.
背景情况:
- 1型糖尿病 (T1D) 治疗面临着供体短缺和β细胞替代疗法的免疫拒绝等挑战.
- 来自干细胞的β细胞 (sBC) 提供了一种可再生的来源,但易受免疫破坏的影响.
研究的目的:
- 设计人类多能干细胞以表达免疫检查点抑制剂CD155.5的高亲和度突变 (Mut) 变体.
- 评估修改后的sBC能够逃避由T细胞和NK细胞介导的免疫攻击的能力.
主要方法:
- 人类多能干细胞被设计为表达野生型 (WT) 或高亲和度突变 (Mut) CD155.5.
- 修改后的细胞分化为sBC,并通过共同培养研究评估它们的免疫相互作用.
- 使用TIGIT阻塞证实了CD155-TIGIT信号在免疫逃避中的作用.
主要成果:
- CD155 Mut-表达的sBC显示了上调的CD155和增强的带结合.
- CD155 Mut sBC通过参与TIGIT抑制了CD8+T细胞和NK细胞的激活和增殖.
- 表达CD155 Mut的sBC显示自身反应性免疫细胞的破坏减少和较低的细胞毒性分子分泌.
结论:
- 高亲和度CD155表达通过利用CD155-TIGIT抑制途径来增强sBC的免疫逃避.
- 这种工程化免疫逃避机制提高了sBC在1型糖尿病的治疗潜力.
- 准CD155-TIGIT信号传递是一种新的策略,可以保护β细胞疗法免受免疫攻击.
相关概念视频
iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
Tissue Renewal without Stem Cells
1.8K
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
1.8K
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K


